Search - tctmd.com

Displaying 501 - 520 of 919

Sort: Relevancy | Date

Presentation NY Valves 2024

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

Presenter: Tsuyoshi Kaneko

June 07, 2024

Presentation NY Valves 2024

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Helge Möllmann

June 07, 2024

Presentation NY Valves 2024

Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients

Presenter: Nino Mihatov

June 07, 2024

Presentation NY Valves 2024

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Bassem M. Chehab

June 07, 2024

Presentation NY Valves 2024

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Presenter: Sebastian Ludwig

June 07, 2024

Presentation NY Valves 2024

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: John K. Forrest

June 07, 2024

Presentation NY Valves 2024

How to Define and Manage Subclinical Leaflet Thrombosis

Presenter: Hasan Jilaihawi

June 07, 2024

Presentation NY Valves 2024

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Presenter: Anita W. Asgar

June 07, 2024

Presentation NY Valves 2024

The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Pradeep K. Yadav

June 07, 2024

Presentation NY Valves 2024

New Design Features and Changing Clinical Topics for TAVR in the Next Decade!

Presenter: Tamim M. Nazif

June 07, 2024

Presentation NY Valves 2024

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Presenter: Steven J. Yakubov

June 07, 2024

Presentation NY Valves 2024

Arial View of Antithrombotic Therapy Post TAVR

Presenter: Thomas Pilgrim

June 07, 2024

Presentation NY Valves 2024

Extraction of Irretrievable Ruptured Balloon During Balloon Aortic Valvuloplasty Using a Bailout Technique

Presenter: Itsik Ben-Dor

June 07, 2024

Presentation NY Valves 2024

Characteristics, Outcomes, and Management of Patients With Degenerated Trifecta Valves

Presenter: Taha Hatab

June 07, 2024

Presentation NY Valves 2024

Acute Abdominal Aortic Perforation Following TAVI

Presenter: Luigi Salemme

June 07, 2024

Presentation NY Valves 2024

ReValve Solutions: The Next Generation of TMVR

Presenter: Charles J. Davidson

June 07, 2024

Presentation NY Valves 2024

More Than TAVR Embolization

Presenter: Itsik Ben-Dor

June 07, 2024

Presentation NY Valves 2024

Feasibility of Redo Transcatheter Aortic Valve Replacement (Redo TAV) in Bicuspid Aortic Valves

Presenter: Atsushi Okada

June 07, 2024

Presentation NY Valves 2024

Not So Fast! Surgical Repair and Replacement Are Still the Gold Standard for AR Therapy!

Presenter: Hiroo Takayama

June 07, 2024

Presentation NY Valves 2024

TAVR Therapy for Chronic AR: Focus on Dedicated TAVR Devices

Presenter: Torsten P. Vahl

June 07, 2024

Advertisement

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

How to Define and Manage Subclinical Leaflet Thrombosis

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities

New Design Features and Changing Clinical Topics for TAVR in the Next Decade!

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Arial View of Antithrombotic Therapy Post TAVR

Extraction of Irretrievable Ruptured Balloon During Balloon Aortic Valvuloplasty Using a Bailout Technique

Characteristics, Outcomes, and Management of Patients With Degenerated Trifecta Valves

Acute Abdominal Aortic Perforation Following TAVI

ReValve Solutions: The Next Generation of TMVR

More Than TAVR Embolization

Feasibility of Redo Transcatheter Aortic Valve Replacement (Redo TAV) in Bicuspid Aortic Valves

Not So Fast! Surgical Repair and Replacement Are Still the Gold Standard for AR Therapy!

TAVR Therapy for Chronic AR: Focus on Dedicated TAVR Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content